GL1X · GenesisL1 explorer

MolNFT v1 · #102582 · protein

Tetra-substituted imidazoles as a new class of inhibitors of the P53- MDM2 interaction

4OQ3 · E3 ubiquitin-protein ligase MDM2: “Tetra-substituted imidazoles as a new class of inhibitors of the P53- MDM2 interaction”. X-ray diffraction, 1 ligand (2V8), 7 pockets (best druggability 0.80). MolNFT v1 #102582 on GenesisL1: 3D…

PDB
4OQ3
Type
protein
Length
367 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
E3 ubiquitin-protein ligase MDM2
EC
6.3.2.-
UniProt
Q00987
Ligands
2V8
Pockets
7 · best druggability 0.80

Structure

x-ray diffraction · 3 distinct chains · 45% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CE3 ubiquitin-protein ligase MDM2 (EC 6.3.2.-)protein9344% helix, 17% strandQ00987
BE3 ubiquitin-protein ligase MDM2 (EC 6.3.2.-)protein9144% helix, 14% strandQ00987
DE3 ubiquitin-protein ligase MDM2 (EC 6.3.2.-)protein9046% helix, 12% strandQ00987

Ligands and binding sites

  • 2V8 · 1-(5-chloro-2-methylphenyl)-5-(3-chlorophenyl)-2-(3-methylphenyl)-1H-imidazole-4-carboxylic acid · ligand · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13880.800.88342V8
21190.450.77192V8
31100.430.76162V8
41140.420.76192V8
5690.340.7614empty

Interfaces

3 interfaces between chains.

  • A–C · 581 Ų buried · 5 hydrogen bonds · protein-protein
  • A–B · 354 Ų buried · 0 hydrogen bonds · protein-protein
  • C–D · 345 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4OQ3 · Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.